Crown Electrokinetics Quarterly Balance Sheets Chart
Quarterly
|
Annual
Crown Electrokinetics Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-09-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2019-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||
| current assets: | |||||||||||||||
| cash | 290,000 | 1,059,000 | 2,056,000 | 36,000 | 2,138,000 | 821,000 | 342,000 | 984,000 | 2,513,000 | 9,701,000 | 15,296,924 | ||||
| prepaid and other current assets | 813,000 | 728,000 | 606,000 | 756,000 | 723,000 | 590,000 | 380,000 | ||||||||
| accounts receivable | 776,000 | 83,000 | 24,788 | ||||||||||||
| note receivable | 576,000 | ||||||||||||||
| total current assets | 2,455,000 | 1,870,000 | 2,662,000 | 792,000 | 2,861,000 | 1,411,000 | 722,000 | 1,667,000 | 3,287,000 | 10,406,000 | 15,642,568 | 289,515 | 692,626 | 599,153 | 109,232 |
| property and equipment | 3,036,000 | 3,129,000 | 2,638,000 | 2,366,000 | 2,528,000 | 1,409,000 | 1,416,000 | 1,092,000 | 851,000 | 484,000 | 209,133 | 148,240 | 106,600 | 87,977 | 110,257 |
| intangible assets | 1,326,000 | 1,382,000 | 1,633,000 | 1,688,000 | 1,744,000 | 1,598,000 | 1,654,000 | 1,709,000 | 1,715,000 | 1,783,000 | 1,649,522 | 204,651 | 214,806 | 224,961 | 255,207 |
| right-of-use assets | 1,533,000 | 701,000 | |||||||||||||
| deferred debt issuance costs | 362,000 | 1,306,000 | 3,847,000 | 5,819,000 | 8,261,000 | 150,000 | |||||||||
| other assets | 165,000 | 139,000 | 33,000 | 33,000 | 213,000 | 180,000 | 403,000 | 403,000 | 402,000 | 28,000 | 20,373 | ||||
| total assets | 8,877,000 | 9,527,000 | 12,166,000 | 12,147,000 | 17,968,000 | 6,590,000 | 6,166,000 | 6,968,000 | 8,473,000 | 12,701,000 | 17,521,596 | 642,406 | 1,014,032 | 912,091 | 630,007 |
| liabilities and stockholders’ equity | |||||||||||||||
| current liabilities: | |||||||||||||||
| accounts payable | 2,297,000 | 1,500,000 | 1,855,000 | 1,822,000 | 1,146,000 | 865,000 | 1,211,000 | 840,000 | 330,000 | 426,000 | 285,149 | 1,182,621 | 976,021 | 1,028,420 | 939,622 |
| accrued expenses | 962,000 | 1,190,000 | 175,000 | 408,000 | 230,000 | 621,000 | 133,000 | 116,000 | 90,000 | 480,000 | 210,898 | 356,315 | 242,737 | 575,297 | 350,443 |
| lease liabilities - current portion | 606,000 | 385,000 | |||||||||||||
| warrant liability | 23,000 | 34,000 | 2,721,000 | 2,332,000 | 972,000 | 2,542,415 | 3,765,699 | 2,314,152 | 1,462,624 | ||||||
| notes payable - current | 93,000 | ||||||||||||||
| deferred revenue | 1,260,000 | ||||||||||||||
| warranty customer liability | 20,000 | 2,000 | |||||||||||||
| total current liabilities | 5,261,000 | 3,776,000 | 2,537,000 | 7,235,000 | 9,016,000 | 4,694,000 | 1,605,000 | 2,400,000 | 935,000 | 1,345,000 | 934,547 | 7,413,847 | 7,605,204 | 6,555,583 | 5,835,797 |
| notes payable - non-current | 328,000 | ||||||||||||||
| lease liabilities - non-current portion | 950,000 | 355,000 | |||||||||||||
| warranty customer liability long term | 20,000 | 2,000 | |||||||||||||
| total liabilities | 6,559,000 | 4,850,000 | 2,892,000 | 7,590,000 | 10,224,000 | 6,060,000 | 3,420,000 | 4,215,000 | 2,749,000 | 1,345,000 | 934,547 | 7,413,847 | 7,605,204 | 6,555,583 | 5,835,797 |
| commitments and contingencies | |||||||||||||||
| stockholders’ equity: | |||||||||||||||
| preferred stock, par value 0.0001; 50,000,000 shares authorized, no shares outstanding | |||||||||||||||
| series a preferred stock, par value 0.0001; 300 shares authorized, 251 shares outstanding as of march 31, 2024 and december 31, 2023; liquidation preference 266 as of march 31, 2024 and 261 as of december 31, 2023 | |||||||||||||||
| series b preferred stock, par value 0.0001; 1,500 shares authorized, 1,443 shares outstanding as of march 31, 2024 and december 31, 2023; liquidation preference 1,530 as of march 31, 2024 and 1,501 as of december 31, 2023 | |||||||||||||||
| series c preferred stock, par value 0.0001; 600,000 shares authorized, 500,756 shares outstanding as of march 31, 2024 and december 31, 2023; liquidation preference 541 as of march 31, 2024 and 531 as of december 31, 2023 | |||||||||||||||
| series d preferred stock, par value 0.0001; 7,000 shares authorized, no shares issued and outstanding as of march 31, 2024 and december 31, 2023; liquidation preference zero as of march 31, 2024 and december 31, 2023 | |||||||||||||||
| series e preferred stock, par value 0.0001; 77,000 shares authorized, no shares issued and outstanding as of march 31, 2024 and december 31, 2023. | |||||||||||||||
| series f preferred stock, par value 0.0001; 9,073 shares authorized, 4,448 shares outstanding as of march 31, 2024 and 4,448 shares outstanding as of december 31, 2023; liquidation preference 4,931 as of march 31, 2024 and 4,753 as of december 31, 2023. | |||||||||||||||
| series f-1 preferred stock, par value 0.0001; 9,052 shares authorized, 653 shares outstanding as of march 31, 2024 and 653 shares outstanding as of december 31, 2023; liquidation preference 722 as of march 31, 2024 and 696 as of december 31, 2023. | |||||||||||||||
| series f-2 preferred stock, par value 0.0001; 9,052 shares authorized, 1,153 shares outstanding as of march 31, 2024 and 1,153 shares outstanding as of december 31, 2023; liquidation preference 1,267 as of march 31, 2024 and 1,371 as of december 31, 2023. | |||||||||||||||
| common stock | 10,000 | 7,000 | 7,000 | 6,000 | 4,000 | 2,000 | 2,000 | 1,000 | 1,000 | 1,000 | 1,486 | 760 | 2,864 | 2,478 | 1,640 |
| additional paid-in capital | 123,915,000 | 121,665,000 | 116,956,000 | 109,381,000 | 98,051,000 | 88,533,000 | 88,597,000 | 85,489,000 | 83,983,000 | 79,659,000 | 73,788,997 | 29,758,066 | 26,082,835 | 21,264,419 | 6,663,488 |
| accumulated deficit | -121,607,000 | -116,995,000 | -107,689,000 | -104,830,000 | -90,311,000 | -88,005,000 | -85,853,000 | -82,737,000 | -78,260,000 | -68,304,000 | -57,203,484 | -36,530,267 | -32,676,871 | -26,910,389 | -11,870,918 |
| total stockholders’ equity | 2,318,000 | 4,677,000 | 9,274,000 | 4,557,000 | 7,744,000 | 530,000 | 2,746,000 | 2,753,000 | 5,724,000 | 11,356,000 | 16,587,049 | ||||
| total liabilities and stockholders’ equity | 8,877,000 | 9,527,000 | 12,166,000 | 12,147,000 | 17,968,000 | 6,590,000 | 6,166,000 | 6,968,000 | 8,473,000 | 12,701,000 | 17,521,596 | ||||
| right of use asset | 1,701,000 | 797,000 | 1,709,000 | 1,842,000 | 1,971,000 | 2,097,000 | 2,218,000 | ||||||||
| lease liability - current portion | 655,000 | 484,000 | 598,000 | 574,000 | 253,000 | 378,000 | 507,000 | ||||||||
| notes payable at fair value | 1,470,000 | 3,191,000 | 1,654,000 | ||||||||||||
| notes payable | 429,000 | 88,000 | 330,000 | 1,519,000 | 8,000 | 8,000 | 8,000 | 8,000 | 439,000 | ||||||
| lease liability - non-current portion | 1,072,000 | 355,000 | 1,208,000 | ||||||||||||
| series a preferred stock, par value 0.0001; 300 shares authorized, 251 shares outstanding as of december 31, 2023 and december 31, 2022; liquidation preference 261 as of december 31, 2023 and zero as of december 31, 2022 | |||||||||||||||
| series b preferred stock, par value 0.0001; 1,500 shares authorized, 1,443 shares outstanding as of december 31, 2023 and december 31, 2022; liquidation preference 1,501 as of december 31, 2023 and zero as of december 31, 2022 | |||||||||||||||
| series c preferred stock, par value 0.0001; 600,000 shares authorized, 500,756 shares outstanding as of december 31, 2023 and december 31, 2022; liquidation preference 531 as of december 31, 2023 and zero as of december 31, 2022 | |||||||||||||||
| series d preferred stock, par value 0.0001; 7,000 shares authorized, no shares issued and outstanding as of december 31, 2023 and 1,058 as of december 31, 2022; liquidation preference zero as of december 31, 2023 and 1,113 as of december 31, 2022 | |||||||||||||||
| series e preferred stock, par value 0.0001; 77,000 shares authorized, 0 shares issued and outstanding as of december 31, 2023 and december 31, 2022 | |||||||||||||||
| series f preferred stock, par value 0.0001; 9,073 shares authorized, 4,448 shares outstanding as of december 31, 2023 and no shares outstanding as of december 31, 2022; liquidation preference 4,753 as of december 31, 2023 and zero as of december 31, 2022 | |||||||||||||||
| series f-1 preferred stock, par value 0.0001; 9,052 shares authorized, 653 shares outstanding as of december 31, 2023 and no shares outstanding as of december 31, 2022; liquidation preference 696 as of december 31, 2023 and zero as of december 31, 2022 | |||||||||||||||
| series f-2 preferred stock, par value 0.0001; 9,052 shares authorized, 1,153 shares outstanding as of december 31, 2023 and no shares outstanding as of december 31, 2022; liquidation preference 1,371 as of december 31, 2023 and zero as of december 31, 2022 | |||||||||||||||
| goodwill | 652,000 | 652,000 | 652,000 | ||||||||||||
| series a preferred stock, par value 0.0001; 300 shares authorized, 251 shares outstanding as of september 30, 2023 and december 31, 2022; liquidation preference 256 as of september 30, 2023 and zero as of december 31, 2022 | |||||||||||||||
| series b preferred stock, par value 0.0001; 1,500 shares authorized, 1,443 shares outstanding as of september 30, 2023 and december 31, 2022; liquidation preference 1,472 as of september 30, 2023 and zero as of december 31, 2022 | |||||||||||||||
| series c preferred stock, par value 0.0001; 600,000 shares authorized, 500,756 shares outstanding as of september 30, 2023 and december 31, 2022; liquidation preference 521 as of september 30, 2023 and zero as of december 31, 2022 | |||||||||||||||
| series d preferred stock, par value 0.0001; 7,000 shares authorized, 0 shares issued and outstanding as of september 30, 2023 and 1,058 as of december 31, 2022; liquidation preference zero as of september 30, 2023 and 1,113 as of december 31, 2022 | |||||||||||||||
| series e preferred stock, par value 0.0001; 77,000 shares authorized, 0 shares issued and outstanding as of september 30, 2023 and december 31, 2022. | |||||||||||||||
| series f preferred stock, par value 0.0001; 9,073 shares authorized, 4,448 shares outstanding as of september 30, 2023 and no shares outstanding as of december 31, 2022; liquidation preference 4,620 as of september 30, 2023 and zero as of december 31, 2022. | |||||||||||||||
| series f-1 preferred stock, par value 0.0001; 9,052 shares authorized, 653 shares outstanding as of september 30, 2023 and no shares outstanding as of december 31, 2022; liquidation preference 1,578 as of september 30, 2023 and zero as of december 31, 2022. | |||||||||||||||
| series f-2 preferred stock, par value 0.0001; 9,052 shares authorized, 1,153 shares outstanding as of september 30, 2023 and no shares outstanding as of december 31, 2022; liquidation preference 1,198 as of september 30, 2023 and zero as of december 31, 2022. | |||||||||||||||
| series a preferred stock, par value 0.0001; 300 shares authorized, 251 shares outstanding as of june 30, 2023 and december 31, 2022; liquidation preference 260 as of june 30, 2023 and 0 as of december 31, 2022 | |||||||||||||||
| series b preferred stock, par value 0.0001; 1,500 shares authorized, 1,443 shares outstanding as of june 30, 2023 and december 31, 2022; liquidation preference 1,492 as of june 30, 2023 and 0 as of december 31, 2022 | |||||||||||||||
| series c preferred stock, par value 0.0001; 600,000 shares authorized, 500,756 shares outstanding as of june 30, 2023 and december 31, 2022; liquidation preference 511 as of june 30, 2023 and 0 as of december 31, 2022 | |||||||||||||||
| series d preferred stock, par value 0.0001; 7,000 shares authorized, 0 shares issued and outstanding as of june 30, 2023 and 1,058 as of december 31, 2022; liquidation preference 0 as of june 30, 2023 and 1,113 as of december 31, 2022 | |||||||||||||||
| series e preferred stock, par value 0.0001; 77,000 shares authorized, 21,000 shares committed pending shareholder approval as of june 30, 2023 and no shares outstanding as of december 31, 2022 | |||||||||||||||
| series f preferred stock, par value 0.0001; 9,073 shares authorized, 5,251 shares outstanding as of june 30, 2023 and no shares outstanding as of december 31, 2022 | |||||||||||||||
| series f-1 preferred stock, par value 0.0001; 9,052 shares authorized, 3,583 shares outstanding as of june 30, 2023 and no shares outstanding as of december 31, 2022. | |||||||||||||||
| series f-2 preferred stock, par value 0.0001; 9,052 shares authorized, 1,153 shares outstanding as of june 30, 2023 and no shares outstanding as of december 31, 2022. | |||||||||||||||
| series a preferred stock, par value 0.0001; 300 shares authorized, 251 shares outstanding as of march 31, 2023 and december 31, 2022; liquidation preference 255 and 251 as of march 31, 2023 and december 31, 2022, respectively | |||||||||||||||
| series b preferred stock, par value 0.0001; 1,500 shares authorized, 1,443 shares outstanding as of march 31, 2023 and december 31, 2022; liquidation preference 1,464 and 1,143 as of march 31, 2023 and december 31, 2022, respectively | |||||||||||||||
| series c preferred stock, par value 0.0001; 600,000 shares authorized, 500,756 shares outstanding as of march 31, 2023 and december 31, 2022; liquidation preference 501 as of march 31, 2023 and december 31, 2022 | |||||||||||||||
| series d preferred stock, par value 0.0001; 7,000 shares authorized, 1,058 shares issued and outstanding as of march 31, 2023 and december 31, 2022; liquidation preference 1,145 and 1,113 as of march 31, 2023 and december 31, 2022, respectively | |||||||||||||||
| series e preferred stock, par value 0.0001; 77,000 shares authorized, 5,000 shares outstanding as of march 31, 2023 and no shares outstanding as of december 31, 2022 | |||||||||||||||
| lease liability | 1,366,000 | 1,815,000 | 1,815,000 | 1,814,000 | |||||||||||
| series a preferred stock, par value 0.0001; 300 shares authorized, 251 shares outstanding as of december 31, 2022 and 2021 | |||||||||||||||
| series b preferred stock, par value 0.0001; 1,500 shares authorized, 1,443 shares outstanding as of december 31, 2022 and 2021 | |||||||||||||||
| series c preferred stock, par value 0.0001; 600,000 shares authorized, 500,756 shares outstanding as of december 31, 2022 and 2021 | |||||||||||||||
| series d preferred stock, par value 0.0001; 7,000 shares authorized, 1,058 shares issued and outstanding as of december 31, 2022; liquidation preference 1,113 as of december 31, 2022; no shares authorized, or outstanding, and no liquidation preference as of december 31, 2021 | |||||||||||||||
| series a preferred stock, par value 0.0001; 300 shares authorized, 251 shares outstanding as of september 30, 2022 and december 31 2021 | |||||||||||||||
| series b preferred stock, par value 0.0001; 1,500 shares authorized, 1,443 shares outstanding as of september 30, 2022 and december 31 2021 | |||||||||||||||
| series c preferred stock, par value 0.0001; 600,000 shares authorized, 500,756 shares outstanding as of september 30, 2022 and december 31, 2021 | |||||||||||||||
| series d preferred stock, par value 0.0001; 7,000 shares authorized, 1,058 shares issued and outstanding as of september 30, 2022; liquidation preference 1,081 as of september 30, 2022; no shares authorized, or outstanding, and no liquidiation peference as of december 31, 2021 | |||||||||||||||
| prepaid & other current assets | 683,000 | 774,000 | 705,000 | 345,644 | 253,906 | 91,702 | 7,302 | 84,444 | |||||||
| shares liability | 1,058,000 | ||||||||||||||
| series a preferred stock, par value 0.0001; 300 shares authorized, 251 shares outstanding as of june 30, 2022 and december 31 2021 | |||||||||||||||
| series b preferred stock, par value 0.0001; 1,500 shares authorized, 1,443 shares outstanding as of june 30, 2022 and december 31 2021 | |||||||||||||||
| series c preferred stock, par value 0.0001; 600,000 shares authorized, 500,756 shares outstanding as of june 30, 2022 and december 31, 2021 | |||||||||||||||
| series a preferred stock, par value 0.0001; 300 shares authorized, 251 shares outstanding as of march 31, december 31, 2022 and 2021, respectively | |||||||||||||||
| series b preferred stock, par value 0.0001; 1,500 shares authorized, 1,443 shares outstanding as of march 31, 2022 and 2021, respectively | |||||||||||||||
| series c preferred stock, par value 0.0001; 600,000 shares authorized, 500,756 shares outstanding as of march 31, 2022 and december 31, 2021, respectively | |||||||||||||||
| series a preferred stock, par value 0.0001; 300 shares authorized, 251 shares outstanding as of september 30, 2021 and march 31, 2021, respectively | |||||||||||||||
| series b preferred stock, par value 0.0001; 1,500 shares authorized, 1,443 shares outstanding as of september 30, 2021 and march 31, 2021, respectively | |||||||||||||||
| series c preferred stock, par value 0.0001; 600,000 shares authorized, 500,756 shares outstanding as of september 30, 2021 and march 31, 2021, respectively | |||||||||||||||
| accrued interest | 464,565 | 394,106 | 372,570 | 306,994 | |||||||||||
| notes payable, net of debt discount of 0 and 405,377, respectively | 438,500 | ||||||||||||||
| related party payable | 25,000 | 49,741 | 49,741 | 31,000 | |||||||||||
| stockholders’ equity | |||||||||||||||
| series a preferred stock, par value 0.0001; 300 shares authorized, 251 shares outstanding as of march 31, 2021 and no shares outstanding as of march 31, 2020 | |||||||||||||||
| series b preferred stock, par value 0.0001; 1,500 shares authorized, 1,443 shares outstanding as of march 31, 2021 and no shares outstanding as of march 31, 2020 | |||||||||||||||
| series c preferred stock, par value 0.0001; 600,000 shares authorized, 500,756 shares outstanding as of march 31, 2021 and no shares outstanding as of march 31, 2020 | 50 | ||||||||||||||
| cash & cash equivalents | 35,609 | 600,924 | 591,851 | ||||||||||||
| liabilities and stockholders’ deficit | |||||||||||||||
| notes payable, net of debt discount of 822,961 and 405,377, respectively | 2,842,931 | ||||||||||||||
| stockholders’ deficit: | |||||||||||||||
| total stockholders’ deficit | -6,771,441 | -6,591,172 | -5,643,492 | -5,205,790 | |||||||||||
| total liabilities and stockholders’ deficit | 642,406 | 1,014,032 | 912,091 | 630,007 | |||||||||||
| revenue | |||||||||||||||
| cost of revenue | 153,500 | ||||||||||||||
| gross loss | -153,500 | ||||||||||||||
| operating expenses: | |||||||||||||||
| research and development | 838,967 | 423,174 | 1,372,522 | 750,395 | |||||||||||
| selling, general and administrative | 1,857,892 | 1,659,612 | 7,937,557 | 1,492,483 | |||||||||||
| total operating expenses | 2,696,859 | 2,082,786 | 9,310,079 | 2,242,878 | |||||||||||
| income from operations | -2,696,859 | -2,082,786 | -9,310,079 | -2,396,378 | |||||||||||
| other income: | |||||||||||||||
| other income | -483 | -54,226 | |||||||||||||
| interest expense | -340,880 | -1,089,804 | -1,234,213 | -393,320 | |||||||||||
| loss on exchange of notes payable for common stock and warrants | -1,498,901 | ||||||||||||||
| loss on extinguishment of debt | -255,046 | -179,400 | -18,200 | ||||||||||||
| change in fair value of warrant liability | -598,899 | -861,365 | 122,909 | -11,482 | |||||||||||
| chang in fair value of derivative liability | 38,771 | ||||||||||||||
| total other income | -1,156,537 | -3,683,696 | -1,151,951 | -404,802 | |||||||||||
| net income | -3,853,396 | -5,766,482 | -10,462,030 | -2,801,180 | |||||||||||
| net income per share | -0.45 | -0.22 | -0.61 | -0.24 | |||||||||||
| weighted-average shares outstanding, basic and diluted: | 8,595,124 | 25,645,519 | 17,342,533 | 11,625,368 | |||||||||||
| notes payable, net of debt discount of 501,370 and 405,377, respectively | 2,176,900 | ||||||||||||||
| notes payable, net of debt discount of 1,439,156 and 405,377, respectively | 2,215,403 | ||||||||||||||
| loss on conversion of notes | -22,447 | ||||||||||||||
| deferred offering costs | 155,311 | ||||||||||||||
| cash overdraft | 8,207 | ||||||||||||||
| notes payable, net of debt discount | 2,736,907 |
We provide you with 20 years of balance sheets for Crown Electrokinetics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Crown Electrokinetics. Explore the full financial landscape of Crown Electrokinetics stock with our expertly curated balance sheets.
The information provided in this report about Crown Electrokinetics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.